Imatinib is effective long term treatment for myeloid leukaemiaBMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7581.1266-c (Published 14 December 2006) Cite this as: BMJ 2006;333:1266
The tyrosine kinase inhibitor imatinib has been a first line treatment for chronic myeloid leukaemia for several years, since early trials showed it was better than existing treatments at preventing progression of the disease and prolonging survival. Observational data from a five …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial